FREE CE: Evolving Management Strategies for nAMD and DME

Activity Overview

Retinal and choroidal vascular diseases are principal causes of blindness for adults around the world. Neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME) are 2 significant contributors to this global vision loss and confer substantial social and economic burdens on patients and society. Anti-vascular endothelial growth factor (VEGF) intravitreal injection therapy has dominated as the standard-of-care treatment for more than 15 years, but poor adherence and high treatment burden have led to suboptimal visual outcomes in the real world compared with clinical trial results. New and emerging agents may help to overcome these issues.

This Community Practice Connection™ program provides an in-depth review of some of the key highlights from the Controversies in Modern Eyecare meeting, held in April 2023. This unique and engaging multimedia activity is ideal for the community-based clinician and focuses on the practical aspects of managing patients with nAMD and DME, putting recent clinical trial data into clinical context. The program is designed for those who did not attend the live meeting and to help reinforce learnings for those who did.

Target Audience

The online educational activity is directed towards optometrists and ophthalmologists.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

• Analyze results of key clinical trials relating to the treat-and-extend strategy that may be used for the treatment of nAMD and DME
• Integrate approaches for optimal patient monitoring and counseling to improve outcomes and quality of life (QoL) for patients living with nAMD and DME
• Formulate an effective multidisciplinary approach between optometrists and ophthalmologists to improve the overall management of retinal diseases